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Purpose: To assess for γD-crystallin (CRYGD) mutation in 2 Saudi patients with cerulean cataract and in a brother of one
of the patients who had coralliform cataract.
Methods: Patients and all of their available relatives underwent ophthalmic examination and subsequent sequencing of
the candidate gene CRYGD.
Results: In the first family, a 4-year-old boy with bilateral cerulean cataract and his 6-year-old brother with similar bluish
lens discoloration but in a coralliform pattern were heterozygous for the p.P23T CRYGD mutation. Their father and 2
older brothers, all of whom underwent childhood cataract surgery, also harbored the mutation while the 2 asymptomatic
immediate family members did not. In the second family, a 7-year-old girl with bilateral cerulean cataract was heterozygous
for the same CRYGD mutation. Details of her family history were limited. The patients in the two families shared a common
disease haplotype.
Conclusions: This first report of p.P23T CRYGD mutation underlying cerulean cataract in the Saudi population strongly
supports the mutation’s relation with the phenotype. Coralliform cataract can represent variable expressivity for the same
mutation rather than a distinct entity.
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family, p.R14C CRYGD mutation segregated with nuclear
cataract in some family members and with coralliform cataract
in others [10]. In a third Chinese family, heterozygous p.G61C
CRYGD mutation segregated with coralliform cataract [11].
To the best of our knowledge mutations in a gene other than
CRYGD have not been associated with coralliform cataract.
The  purpose  of  this  study  is  to  assess  for  CRYGD
mutations in 2 Saudi patients with cerulean cataract and in a
brother of one of the patients who had coralliform cataract.
CRYGD was selected as a candidate gene because one patient
with cerulean cataract had a brother with coralliform cataract
and both types of cataract have been previously-associated
with CRYGD mutations [6-11].
METHODS
Institutional  review  board  approval  was  granted  for  this
report.  Informed  consent  was  obtained  from  the  2
participating families, who were not known to be related to
each  other.  Clinical  ophthalmic  assessment  and  CRYGD
sequencing was done on a diagnostic basis for the 2 affected
patients, a brother of one of the patients who had coralliform
cataract, and all available family members. SNP haplotypes
for CRYGD were constructed, and CRYGD was sequenced in
ethnically-matched controls.
Clinical: Ophthalmic examination consisted of visual
acuity,  slit-lamp  biomicroscopy,  intraocular  pressure,
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Cerulean (“blue-dot”) cataract is an unusual phenotype
characterized by dominant early (juvenile) onset of multiple
bluish and white opacities predominantly in the lens cortex
with  occasional  radial  central  lesions  [1].  The  most
commonly-documented cause is heterozygous p.Q155X βB2-
crystallin (CRYBB2) mutation, which has been reported in 3
affected families – one from America [2], one from India [3],
and one from China [4]. In addition, 2 other heterozygous gene
mutations  have  been  associated  with  cerulean  cataract  –
p.K297R mutation in MAF (v-maf avian musculoaponeurotic
fibrosarcoma oncogene homolog) in one Indian family (with
variable microcornea) [5] and p.P23T CRYGD mutation in
one Moroccan family [6,7]. Heterozygous p.P23T CRYGD
mutation has also been associated with coralliform cataract,
an even less-frequently reported dominant cataract phenotype
which  is  characterized  by  generally  static  central  radial
lenticular opacities that resemble sea coral [1]. Coralliform
cataract due to p.P23T CRYGD mutation has been reported
in  an  affected  Caucasian  [8]  and  Chinese  family  [9].  In
addition, 2 other heterozygous CRYGD mutations have also
been associated with coralliform cataract. In another Chinesepupillary  examination,  ocular  motility  assessment,  fundus
examination, and cycloplegic refraction (cyclopentolate 1%).
Genetic:  Genomic  DNA  was  extracted  from  whole
blood anti-coagulated with EDTA using the Purgene Gentra
DNA  Extraction  Kit  (Cat.  #  D-5000;  Gentra  Systems,
Minneapolis,  MN)  according  to  the  manufacturers
instructions. The DNA was quantified spectrophotometrically
and stored in aliquots at -20 °C until required.
PCR  amplification  and  DNA  sequencing:  PCR
amplification was performed on a thermocycler (DNA Engine
Tetrad; MJResearch, Inc., Hercules, CA) in a total volume of
25 µl, containing 10 ng DNA, 50 mM KCl, 10 mM Tris-HCl
(pH 9.0), 1.5 mM MgCl2, 0.1% Triton X-100, 0.25 mM of
each dNTP, 0.8 µM of each primer and 0.5 Units of Taq
polymerase  (D-40724;  QIAGEN,  Hilden,  Germany).  For
PCR, an initial denaturation step at 95 ºC for 10 min was
followed by 40 cycles of denaturation at 95 ºC for 30 s, with
annealing at 59 ºC for 30 s and extension at 72 ºC for 30 s
followed by a final extension step of 72 ºC for 10 min. The
primers  used  for  amplification  of  the  coding  regions  of
CRYGD are listed in Table 1. All exons and their intronic
boundaries of CRYGD were sequenced using an Amersham
ET  Dye  Terminator  Cycle  Sequencing  Kit  (Amersham
Biosciences, Piscataway, NJ) following the manufacturer’s
instructions.  Sequence  analysis  (3730xl  DNA  Analyzer;
Applied Biosystems, Foster City, CA) was performed using
the  SeqManII  module  of  the  Lasergene  (DNA  Star  Inc.,
Madison, WI) software package using normal sequence for
comparison. A haplotype for CRYGD was constructed using
intragenic and surrounding SNPs. CRYGD sequencing was
done in 96 Saudi controls (192 chromosomes).
RESULTS:
Family 1 (Figure 1A): A 4-year-old boy with no other history
of  medical  disease  was  examined  because  of  worsening
photophobia. There was a family history of cataract surgery
for juvenile cataract in 2 older brothers and the father. A 6-
year-old  brother  similarly  complained  of  worsening
photophobia while the mother and other older brother were
asymptomatic.  The  parents  were  not  consanguineous.
Ophthalmic  examination  of  the  referred  child  (II.5)  was
significant for bilateral cerulean (“blue-dot”) cataract (Figure
2) with approximately 20/40 visual acuity in either eye. His
symptomatic brother (II.4) had a medical history significant
for difficult delivery, cerebral palsy, difficulty hearing, and
developmental delay. Vision could not be quantified because
Family  2  (Figure  1B):  A  7-year-old  girl  had  been
diagnosed with visually-significant congenital cataract soon
after birth but never underwent treatment. There was no other
history of medical disease. The mother was unaware of any
family history of childhood eye disease. According to the
mother all siblings of the referred child (3 siblings and 9 step-
siblings) were asymptomatic. The parents were first cousins.
Ophthalmic  examination  of  the  referred  child  (II.5)  was
significant  for  bilateral  cerulean  cataract  (Figure  5)  with
visual acuity of 20/400 in either eye. Only the referred child
was  available  for  ophthalmic  evaluation  and  CRYGD
sequencing, which revealed heterozygous p.P23T mutation
(c.C67A).
Analysis of SNPs flanking CRYGD revealed a common
disease  haplotype  for  the  2  families  (Table  2).  CRYGD
Figure 1. Family pedigrees. The pedigrees of family 1 (A) and family
2  (B)  are  shown.  Symbols  with  numbers  underneath  represent
individuals who participated in the study.
TABLE 1. CRYGD PRIMERS.
Exon ID Forward Reverse
Exon 1-2 CCCGTGGTCTAGCACAGC TGCTTATGTGGGGAGCAAAC
Exon 3 CTGTGCTCGGTAATGAGGAG CCATTTGCCTCGTGTGTG
The primers used for gene sequencing were as shown. The GenBank accession number used for CRYGD was U66583.
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of  developmental  delay.  Ophthalmic  examination  was
significant for bilateral bluish lens discoloration like in his
brother but in a coralliform pattern (Figure 3). Ophthalmic
examination of the individuals with a history of childhood
cataract surgery (I.1, II.1, and II.3) was significant for bilateral
pseudophakia. Ophthalmic examination of the asymptomatic
individuals  (I.2  and  II.2)  was  unremarkable.  CRYGD
sequencing revealed heterozygous p.P23T CRYGD mutation
(c.C67A) in the 2 boys with cataract (II.4 and II.5) and the 3
pseudophakic individuals (I.1, II.1, and II.3) [Figure 4]. The
mutation was not detected in the 2 asymptomatic individuals
(I.2, II.2).sequencing  of  controls  from  the  Saudi  population  (192
chromosomes) was negative for the p.P23T variant.
DISCUSSION
Heterozygous p.P23T CRYGD mutation has been reported as
a cause of cerulean cataract only once previously, in a single
Moroccan family [6,7]. The identification of this mutation in
2 Saudi families with cerulean cataract and a common disease
haplotype is further evidence for the p.P23T variant as a cause
for  this  rare  phenotype.  In  addition,  the  finding  of
heterozygous p.P23T mutation in the patient’s brother with
coralliform  cataract  suggests  coralliform  cataract  and
cerulean cataract can represent forms of variable expressivity
rather than distinct clinical entities. This idea is also supported
by 2 previous reports that similarly described the p.P23T
Figure 2. Cerulean cataract in family 1. The left eye of the boy with
cerulean  cataract  is  shown.  Multiple  bluish  and  white  opacities
predominantly  in  the  lens  cortex  with  occasional  radial  central
lesions are apparent.
Figure 3. Coralliform cataract in family 1. The right eye of the boy
with coralliform cataract is shown (the brother of the patient from
Figure 2). Central radial lenticular opacities with a resemblance to
sea coral are apparent.
CRYGD mutation as a cause for coralliform cataract [8,9].
Although the phenotypic description of the Moroccan family
with cerulean cataract specifically denied that any individual
in the family had coralliform cataract, careful inspection of
Figure  1B  in  that  report  reveals  what  appears  to  be  a
coralliform cataract [7].
Heterozygous p.P23T CRYGD mutation apparently has
several  measurable  effects  on  γD-crystallin  but  without
significant  loss  in  stability  of  the  protein  [6,8,12,13].
Solubility  experiments  show  that  the  p.P23T  mutant  has
significantly decreased solubility when compared to wild-
type γD-crystallin [12,13]. The physical basis for this may
relate to the position of Pro23 on the edge of one of the β-
sheets of γD-crystallin. Proline in the edge strand of a β -
sandwich  minimizes  the  potential  for  edge-to-edge
aggregation events; therefore, its loss in the p.P23T mutant
would be expected to lead to increased precipitation of the
protein [12,13]. Other changes in secondary structure of the
Figure  4.  DNA  chromatograms  of  family  1.  CRYGD  sequence
chromatograms from the first family highlight the mutation and a
novel silent SNP.
Figure 5. Cerulean cataract in family 2. The right eye of the girl with
cerulean  cataract  is  shown.  Multiple  bluish  and  white  opacities
predominantly  in  the  lens  cortex  with  occasional  radial  central
lesions are apparent.
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conformations  with  a  commensurate  increase  in  β-sheet
contents [12]. Despite the decrease in solubility and local
alteration of secondary structure, the p.P23T mutant does not
have an appreciable loss of stability [12,13]. The absence of
the p.P23T variant in our controls and evolutionary analysis
of position 23 in the predicted protein [14] both support the
pathogenecity of p.P23T CRYGD mutation.
Both  intrafamilial  and  interfamilial  phenotypic
variability  in  autosomal  dominant  cataract  for  the  same
genetic mutation is a recognized phenomenon [1]. In addition
to cerulean cataract and coralliform cataract, the heterozygous
p.P23T CRYGD mutation has been associated with lamellar
cataract in an Indian family [15] and fasciculiform cataract in
a Chinese family [16]. The most common cause of cerulean
cataract – heterozygous p.Q155X CRYBB2 mutation – has
also been associated with Coppock-like cataract in a Swiss
family [17], progressive polymorphic cataract in a Chinese
family [18], and cataract with marked intrafamilial variability
in a Chilean family [19]. The other reported cause of cerulean
cataract (with variable microcornea) – a heterozygous MAF
mutation (p.K297R) – has not been associated with another
phenotype  to  the  best  of  our  knowledge.  Regarding
coralliform cataract, p.R14C CRYGD mutation has also been
associated with progressive punctuate juvenile cataract (in a
family of unspecified ethnicity) [20] while the p.G61C variant
has not been associated with another phenotype to the best of
our knowledge. The interaction of background environmental
and/or genetic factors with a given crystalline mutation is what
leads to a final lens phenotype.
This  report  of  p.P23T  CRYGD  mutation  underlying
cerulean cataract in the Saudi population is the second time
the association has been described [6,7] and thus supports
causation of the phenotype by the genotype. The finding of
the variant in the patient’s brother with coralliform cataract is
the  third  time  the  p.P23T  CRYGD  mutation  has  been
associated with coralliform cataract [8,9] and supports the
concept  of  coralliform  and  cerulean  cataract  as  forms  of
variable expressivity rather than distinct entities.
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